Abstract:Abstract Designing entirely new protein structures remains challenging because we do not fully understand the biophysical determinants of folding stability. Yet some protein folds are easier to design than others. Previous work identified the 43-residue αββα fold as especially challenging: the best designs had only a 2% success rate, compared to 39-87% success for other simple folds (1). This suggested the αββα fold would be a useful model system for gaining a deeper understanding of folding stability determinants and for testing new protein design methods. Here, we designed over ten thousand new αββα proteins and found over three thousand of them to fold into stable structures using a high-throughput protease-based assay. Nuclear magnetic resonance, hydrogen-deuterium exchange, circular dichroism, deep mutational scanning, and scrambled sequence control experiments indicated that our stable designs fold into their designed αββα structures with exceptional stability for their small size. Our large dataset enabled us to quantify the influence of universal stability determinants including nonpolar burial, helix capping, and buried unsatisfied polar atoms, as well as stability determinants unique to the αββα topology. Our work demonstrates how large-scale design and test cycles can solve challenging design problems while illuminating the biophysical determinants of folding. Significance Most computationally designed proteins fail to fold into their designed structures. This low success rate is a major obstacle to expanding the applications of protein design. In previous work, we discovered a small protein fold that was paradoxically challenging to design (only a 2% success rate) even though the fold itself is very simple. Here, we used a recently developed high-throughput approach to comprehensively examine the design rules for this simple fold. By designing over ten thousand proteins and experimentally measuring their folding stability, we discovered the key biophysical properties that determine the stability of these designs. Our results illustrate general lessons for protein design and also demonstrate how high-throughput stability studies can quantify the importance of different biophysical forces.

The Challenge to the Rule of Homology Modeling: Folding Mechanism Study of Protein GA and GB with High Sequence Identity but Different Native Structures

Even With Nonnative Interactions, The Updated Folding Transition States Of The Homologs Proteins G & L Are Extensive And Similar

The Folding Transition State of Protein L is Extensive with Nonnative Interactions (and Not Small and Polarized)

Protein folding simulations: from coarse-grained model to all-atom model.

Protein Folding Simulations: from Coarse-Grained Model to All-Atom Model

Probing Possible Downhill Folding: Native Contact Topology Likely Places a Significant Constraint on the Folding Cooperativity of Proteins with ∼40 Residues

Cooperativity, Local-Nonlocal Coupling, and Nonnative Interactions: Principles of Protein Folding from Coarse-Grained Models

Folding Behavior of Ribosomal Protein S6 Studied by Modifiedgo¯-Like Model

The role of hydrophobic interactions in folding of $β$-sheets

All-atom Replica Exchange Molecular Simulation of Protein BBL

Model Study of Prionlike Folding Behavior in Aggregated Proteins

Interplaying Roles of Native Topology and Chain Length in Marginally Cooperative and Noncooperative Folding of Small Protein Fragments

Dissecting the stability determinants of a challenging de novo protein fold using massively parallel design and experimentation

Matching Simulation and Experiment: A New Simplified Model for Simulating Protein Folding

What is the Origin of Those Common Structures of Protein-Model Chains?

Complex Folding Pathways in a Simple Beta-Hairpin

Effects of Turn Stability and Side-Chain Hydrophobicity on the Folding of Β-Structures

Entropy-Enthalpy Compensations Fold Proteins in Precise Ways

Folding of Proteins with an All-Atom Go-model.

Heterogeneous folding landscapes and predetermined breaking points within a protein family

Simple models of protein folding and of non--conventional drug design